FDA Inspection 1228620 — Aarvy Healthcare Super Speciality Hospital
The FDA completed an inspection of Aarvy Healthcare Super Speciality Hospital on Jan 9, 2024 in Gurugram. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 9, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gurugram (India)
Additional Details
Clinical BA/BE